Newborn Screening for Neuromuscular Disorders, Disorders of Glycogen Metabolism, and Fatty Acid Oxidation

Author:

Angelini Corrado

Abstract

Newborn screening for neuromuscular disorders and glycogen or fatty acid oxidation disorders aims to identify infants at risk for these conditions, allowing for early intervention and management. While not all neuromuscular disorders currently have established newborn screening programs, there are various disorders for which screening is available or under investigation. Neuromuscular disorders encompass a wide range of conditions that affect the nerve, muscle, or the connection between them. Examples include spinal muscular atrophy (SMA), myotonic dystrophy, and Pompe disease (GSD II). Each disorder has different genetic causes, clinical presentations, and screening approaches. One example of successful newborn screening is for SMA, a genetic disorder caused by the loss of function of the Survival Motor Neuron 1 (SMN1) gene. This screening involves testing newborns' bloodspots for the absence or low levels of SMN1 gene product (protein), and if detected, further confirmatory genetic testing is performed. Early diagnosis of SMA is also crucial for treatments that are now available. In this article, we deal with various types of muscular dystrophy (DMD, BMD, FSHD), mitochondrial diseases, FAO disorders, and carnitine cycle defects.

Publisher

LIDSEN Publishing Inc

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3